JPS6284024A - 結合組織繊維加水分解物から抽出してなる繊維芽細胞増殖促進剤 - Google Patents
結合組織繊維加水分解物から抽出してなる繊維芽細胞増殖促進剤Info
- Publication number
- JPS6284024A JPS6284024A JP60225666A JP22566685A JPS6284024A JP S6284024 A JPS6284024 A JP S6284024A JP 60225666 A JP60225666 A JP 60225666A JP 22566685 A JP22566685 A JP 22566685A JP S6284024 A JPS6284024 A JP S6284024A
- Authority
- JP
- Japan
- Prior art keywords
- molecular weight
- connective tissue
- cell proliferation
- promoting
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000835 fiber Substances 0.000 title claims abstract description 21
- 210000002808 connective tissue Anatomy 0.000 title claims abstract description 19
- 210000002950 fibroblast Anatomy 0.000 title claims abstract description 12
- 230000004663 cell proliferation Effects 0.000 title abstract description 19
- 230000001737 promoting effect Effects 0.000 title abstract description 9
- 239000003795 chemical substances by application Substances 0.000 title abstract description 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 15
- 230000035755 proliferation Effects 0.000 claims abstract description 11
- 230000000694 effects Effects 0.000 abstract description 18
- 210000003491 skin Anatomy 0.000 abstract description 13
- 238000000605 extraction Methods 0.000 abstract description 5
- 238000000108 ultra-filtration Methods 0.000 abstract description 5
- 241000124008 Mammalia Species 0.000 abstract description 4
- 210000004204 blood vessel Anatomy 0.000 abstract description 4
- 231100000135 cytotoxicity Toxicity 0.000 abstract description 4
- 230000003013 cytotoxicity Effects 0.000 abstract description 4
- 210000003041 ligament Anatomy 0.000 abstract description 4
- 210000001519 tissue Anatomy 0.000 abstract description 4
- 230000003301 hydrolyzing effect Effects 0.000 abstract description 3
- 241001465754 Metazoa Species 0.000 abstract description 2
- 238000000502 dialysis Methods 0.000 abstract description 2
- 238000001641 gel filtration chromatography Methods 0.000 abstract description 2
- 238000004255 ion exchange chromatography Methods 0.000 abstract description 2
- 230000008929 regeneration Effects 0.000 abstract description 2
- 238000011069 regeneration method Methods 0.000 abstract description 2
- 238000005185 salting out Methods 0.000 abstract description 2
- 244000144977 poultry Species 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 description 21
- 239000000126 substance Substances 0.000 description 15
- 238000000034 method Methods 0.000 description 13
- 102000004196 processed proteins & peptides Human genes 0.000 description 10
- 230000010261 cell growth Effects 0.000 description 8
- 239000002537 cosmetic Substances 0.000 description 7
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 6
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 229940126864 fibroblast growth factor Drugs 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 239000003630 growth substance Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000013076 target substance Substances 0.000 description 6
- 238000010998 test method Methods 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 102000016942 Elastin Human genes 0.000 description 5
- 108010014258 Elastin Proteins 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 229920002549 elastin Polymers 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- 229920005654 Sephadex Polymers 0.000 description 3
- 239000012507 Sephadex™ Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- 241000700199 Cavia porcellus Species 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 210000001626 skin fibroblast Anatomy 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- WCVOGSZTONGSQY-UHFFFAOYSA-N 2,4,6-trichloroanisole Chemical compound COC1=C(Cl)C=C(Cl)C=C1Cl WCVOGSZTONGSQY-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 206010033546 Pallor Diseases 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108010059712 Pronase Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 239000012506 Sephacryl® Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- -1 alkalis Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 210000003969 blast cell Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 210000003126 m-cell Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 239000007923 nasal drop Substances 0.000 description 1
- 229940100662 nasal drops Drugs 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 238000000751 protein extraction Methods 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000011146 sterile filtration Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60225666A JPS6284024A (ja) | 1985-10-09 | 1985-10-09 | 結合組織繊維加水分解物から抽出してなる繊維芽細胞増殖促進剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60225666A JPS6284024A (ja) | 1985-10-09 | 1985-10-09 | 結合組織繊維加水分解物から抽出してなる繊維芽細胞増殖促進剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6284024A true JPS6284024A (ja) | 1987-04-17 |
| JPH0424329B2 JPH0424329B2 (enrdf_load_stackoverflow) | 1992-04-24 |
Family
ID=16832875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60225666A Granted JPS6284024A (ja) | 1985-10-09 | 1985-10-09 | 結合組織繊維加水分解物から抽出してなる繊維芽細胞増殖促進剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6284024A (enrdf_load_stackoverflow) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008507135A (ja) * | 2004-07-15 | 2008-03-06 | ゲルコアー リミテッド ライアビリティ カンパニー | 反射板を有するｌｅｄ照明システム |
| EP2074985A2 (en) | 2006-08-11 | 2009-07-01 | Toyo Boseki Kabushiki Kasisha | Activator including biosurfactant as active ingredient, mannosyl erythritol lipid, and production method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59152333A (ja) * | 1983-02-08 | 1984-08-31 | パルフューム・クリスチャン・ディオール | 細胞増殖の刺激方法 |
-
1985
- 1985-10-09 JP JP60225666A patent/JPS6284024A/ja active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59152333A (ja) * | 1983-02-08 | 1984-08-31 | パルフューム・クリスチャン・ディオール | 細胞増殖の刺激方法 |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008507135A (ja) * | 2004-07-15 | 2008-03-06 | ゲルコアー リミテッド ライアビリティ カンパニー | 反射板を有するｌｅｄ照明システム |
| EP2074985A2 (en) | 2006-08-11 | 2009-07-01 | Toyo Boseki Kabushiki Kasisha | Activator including biosurfactant as active ingredient, mannosyl erythritol lipid, and production method thereof |
| US7989599B2 (en) | 2006-08-11 | 2011-08-02 | Toyo Boseki Kabushiki Kaisha | Activator including biosurfactant as active ingredient, mannosyl erythritol lipid, and production method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0424329B2 (enrdf_load_stackoverflow) | 1992-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Becker et al. | Final report of the safety assessment of hyaluronic acid, potassium hyaluronate, and sodium hyaluronate | |
| KR101644985B1 (ko) | 천연(텔로펩티드) 태반 콜라겐 조성물 | |
| JPS63502985A (ja) | 角膜基質創傷の治療のための組成物 | |
| HU225490B1 (en) | Extracts of shark cartilage and process for producing them | |
| EP0711171B1 (en) | A pharmaceutical or cosmetic composition comprising a colostrum fraction and its medical use | |
| JPH0661262B2 (ja) | 細胞増殖の刺激方法 | |
| CN110538312A (zh) | 一种皮肤创伤修复软膏及其制备方法 | |
| CN113337565A (zh) | 一种具有显著皮肤晒伤防护作用的海洋生物活性肽及其制备方法和应用 | |
| CN113481271A (zh) | 一种可有效减轻皮肤晒伤的海洋生物活性肽及其制备方法和应用 | |
| KR102161850B1 (ko) | 히알루론산과 동결건조된 줄기세포 유래 엑소좀의 조합을 유효성분으로 포함하는 창상 치료 또는 창상 치료 촉진용 조성물 | |
| CN111420023B (zh) | 含i型胶原和透明质酸的复合物及制备和用途 | |
| JP4689039B2 (ja) | ファゴサイトーシスおよびｉｃａｍ−１発現を調節するための組成物および方法 | |
| JP4726300B2 (ja) | 移植用マトリックス・タンパク質組成物 | |
| WO2015122592A1 (ko) | 상처 치유 촉진용 조성물 | |
| JP5539609B2 (ja) | 血管形成を促進するためのシカ枝角抽出物 | |
| JPS6284024A (ja) | 結合組織繊維加水分解物から抽出してなる繊維芽細胞増殖促進剤 | |
| DE60008077T2 (de) | Matrixproteinzusammensetzungen um Apoptose zu induzieren | |
| JPH0450293B2 (enrdf_load_stackoverflow) | ||
| JP3805975B2 (ja) | 創傷治癒剤 | |
| JP2021155429A (ja) | 皮膚炎症抑制用ペプチドおよびそれを含む皮膚炎症の予防または治療用組成物 | |
| KR101885591B1 (ko) | 휴매닌 또는 이의 유사체를 유효성분으로 함유하는 창상 치료용 약학적 조성물 | |
| JPH0665041A (ja) | 皮膚外用剤 | |
| JP7668427B2 (ja) | プロテオグリカンの製造方法およびプロテオグリカン | |
| WO2020111743A1 (ko) | 지방 생성을 자극하는 펩타이드, 조성 및 방법 | |
| Copenhagen | 7th Joint Meeting of the European Tissue Repair Society (ETRS) with the Wound Healing Society |